Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Free4Flow
NCT01418118Phase 4Completed
- Sponsor
- Oxford University Hospitals
- Start
- Oct 2008
- Primary completion
- Feb 2010
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of epinephrine, norepinephrine, dobutamine and dopexamine in hypotension, sponsored by Oxford University Hospitals. Primary endpoint: Absolute change in transfer function (flap vascular resistance) after pressor infusion at 4 hours. Started Oct 2008; status: completed.
02
Drugs
epinephrinenorepinephrinedobutaminedopexamine
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT01418118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01418118.